Strabismus in Thyroid Eye Disease

Strabismus means the two eyes are not lined up. One eye points in a slightly different direction than the other eye. Thyroid Eye Disease (TED) is an autoimmune problem. The body’s defense system becomes over-active and mistakenly attacks the tissues inside the eye socket. The tissues that get inflamed are the eye muscles and the soft fat around the eye. The eye muscles swell in the active phase. Later the muscles can become stiff and scarred. Swollen or stiff muscles cannot slide and stretch in a normal way. This makes the eyes pull in different directions. That mis-pull causes strabismus. Strabismus in TED is usually “restrictive.” This means the muscle is too tight to let the eye move freely. It is not mainly a nerve problem, and it is not mainly a weak muscle problem. It is mainly a tight muscle problem.

Strabismus means the two eyes are not pointing in the same direction at the same time. In thyroid eye disease (TED), the body’s immune system mistakenly attacks the tissues around the eyes. The eye muscles become inflamed and then stiff and tight. Because some muscles are swollen and later turn fibrous and hard, the affected eye (or both eyes) cannot move freely, and the eyes no longer line up together. This misalignment causes double vision (diplopia), eye strain, abnormal head posture, and difficulty with daily tasks such as reading and driving. TED-strabismus is usually restrictive—the problem is not a weak muscle but a tight, stuck muscle (most often the inferior rectus and medial rectus). That is why double vision often shows up when you look up or to the side, and why measurements can change with different gaze directions. Over time, untreated misalignment can reduce quality of life, limit work, and increase the risk of accidents. Restoring straight eye alignment and comfortable single vision is therefore a core goal of TED care. (For clinical overviews and care sequences—decompression → strabismus → eyelid surgery—see international guidelines and consensus statements. PMC+1)

In TED, the inferior rectus muscle (the muscle under the eye) is most often affected. When it becomes tight, the eye is pulled downward, and it is hard to look up. The medial rectus muscle (the muscle toward the nose) is next most often affected. When it becomes tight, the eye is pulled inward, and it is hard to look out to the side. Less often the superior rectus (top muscle) or the lateral rectus (temple side muscle) are involved. Because the problem is often uneven between the two eyes, double vision is common. People with TED often also have bulging eyes, eyelid retraction, eye redness, and surface dryness. These features can make the double vision feel worse because the eyes are already irritated and strained.

Strabismus can start in the active, inflamed phase of TED. It can also remain or even become more fixed in the quiet, scarred phase. That is why some people have temporary changes early on and more stable misalignment later. Treatment choices depend on the phase. In the active phase, the goal is to calm inflammation and help the person cope with double vision. In the stable phase, the goal is to correct the fixed misalignment.

---

Types (patterns) of strabismus

Vertical strabismus (hypotropia or hypertropia).
This is the most common form. A tight inferior rectus pulls the eye down (hypotropia). The person cannot look up well. They may tilt their chin up to fuse images. Less often a tight superior rectus pulls the eye up (hypertropia) and makes it hard to look down. Vertical misalignment often changes with gaze direction. It can be small in straight-ahead gaze but larger when looking up or down.

Horizontal strabismus (esotropia or exotropia).
A tight medial rectus pulls the eye inward (esotropia). The person may have more double vision when looking far away or to the side. A tight lateral rectus (less common) can pull the eye outward (exotropia). Horizontal strabismus may worsen with fatigue or at night.

Mixed vertical and horizontal strabismus.
Many people have both a vertical and a horizontal component. For example, one eye is down and in. This mixed pattern often creates double vision in many directions of gaze. It makes reading and driving especially hard.

Incomitant strabismus.
“Incomitant” means the amount of misalignment changes with gaze direction. This is typical in TED. The angle can be small when looking one way and large when looking another way. This is different from childhood “comitant” strabismus, where the angle is almost the same in every gaze.

Gaze-dependent diplopia.
Some people only see double when they look up, down, left, or right. They may learn a head posture to keep their eyes in a position where the images join. This is a coping method that helps them function.

Torsional component (twist).
If muscles that control eye rotation are involved, there can be torsion. The image may appear slightly tilted. People describe this as the horizon looking slanted. Torsion can be subtle but very disturbing.

Intermittent versus constant strabismus.
Early in the disease, inflammation and swelling can fluctuate. Double vision can come and go. Later, scarring makes the angle more constant. Constant double vision is very bothersome and needs measurement and targeted treatment.

Small-angle strabismus (microstrabismus).
Some patients have a small but symptomatic angle. Small angles can still cause severe reading problems and eye strain. They often respond to small prism corrections.

Post-decompression or post-surgery strabismus.
After orbital decompression surgery, the eye position can change. The muscles can shift, and strabismus may appear or change. After strabismus surgery, scar tissue can also change the angle over time. These patterns are considered acquired and iatrogenic (treatment-related).

Active-phase versus inactive-phase strabismus.
In the active phase, muscles are swollen and painful, and the angle can vary. In the inactive phase (usually after 6–18 months), inflammation is quiet, and the angle is stable. Surgeons prefer to operate in the inactive phase because the target is more predictable.

---

Causes and contributors

1. Autoimmune inflammation of eye muscles.
   The immune system attacks the muscle tissue. The muscle absorbs water and swells. A swollen muscle cannot glide smoothly, and it pulls the eye off center.

2. Build-up of gel-like molecules in muscle.
   Sugary molecules called glycosaminoglycans collect inside the muscle. They draw in water and make the muscle thick. The thick muscle becomes stiff and restricts movement.

3. Fibrosis (scar tissue) after inflammation.
   After months of swelling, the body lays down scar tissue. Scar tissue is tough and less elastic. A fibrotic muscle behaves like a short, tight band.

4. Inferior rectus tightness.
   The lower muscle is often the first and most affected. It pulls the eye down and blocks up-gaze. This creates vertical double vision, especially when looking up or reading at a music stand.

5. Medial rectus tightness.
   The inner muscle becomes tight and pulls the eye inward. Looking out to the side becomes hard. Distance driving and watching TV can be affected.

6. Superior rectus involvement.
   When the top muscle is tight, the eye rides high. Looking down to read or walk down stairs is difficult. People may lower their chin to fuse images.

7. Lateral rectus involvement.
   This is less common but can pull the eye outward. It creates outward deviation or mixed patterns. Side-gaze tasks can be limited.

8. Orbital fat expansion.
   Inflamed fat takes up more space and pushes the eye forward (proptosis). The forward shift changes how the muscles wrap around the eye. This can change alignment and worsen double vision.

9. Crowding at the orbital apex.
   Thick muscles crowd the back of the orbit. This can press on the optic nerve in severe cases. Even without nerve damage, crowding disturbs muscle paths and causes misalignment.

10. Pain and guarding.
    Inflamed muscles hurt when moved. People avoid certain eye movements. Avoidance leads to stiffness and secondary tightness, which then fixes the strabismus.

11. Decompensation of a hidden phoria.
    Many people have a small “hidden” misalignment that the brain controls. Illness and eye strain can unmask it. TED stress, pain, and blur make the brain lose that control, turning a phoria into a tropia.

12. Vision blur from dry eye.
    Dryness and exposure from eyelid retraction and proptosis cause blur. The brain has a harder time fusing images when one image is blurred. The misalignment then becomes more obvious.

13. Thyroid hormone imbalance.
    Abnormal thyroid levels affect muscle metabolism. They do not cause the restriction alone, but they make the orbital disease more active. Active disease increases swelling and strabismus.

14. Smoking.
    Smoking worsens TED activity and scarring. It increases inflammation and makes treatment less effective. Smokers have more severe and longer-lasting strabismus.

15. Systemic inflammation and stress.
    General body inflammation can fuel orbital inflammation. High stress hormones can also worsen disease flares. Flares increase swelling and double vision.

16. Orbital decompression surgery effects.
    Surgery can shift the eye and the pulleys that guide the muscles. The new geometry can reveal or change strabismus. This is a known trade-off when creating space to save the optic nerve or relieve exposure.

17. Strabismus surgery scarring.
    Surgery to correct strabismus can trigger scar tissue. Scar tissue sometimes pulls the eye more than intended or less than intended. Adjustments may be needed later.

18. Radiation therapy effects.
    Orbital radiotherapy reduces inflammation but can later cause fibrosis in some tissues. This can change muscle elasticity and alignment.

19. Aging of connective tissues.
    With age, ligaments and pulleys around the eye lose elasticity. TED adds stiffness on top of aging changes. The combined effect may tip the balance toward misalignment.

20. Prolonged abnormal head posture.
    When people tilt their head to fuse images for months, some muscles tighten in that posture. This can reinforce the strabismus pattern and make it more fixed.

---

Symptoms

1. Double vision (diplopia).
   Two images are seen instead of one. They can be side-by-side, one above the other, or diagonal. It is worse in some directions of gaze.

2. Eye misalignment that others notice.
   One eye looks slightly in, out, up, or down. Photos may show the eyes are not pointing the same way.

3. Limited eye movement.
   The eye will not move fully up, down, in, or out. It can feel like the eye hits a “stop.” This limit is a hallmark of restrictive disease.

4. Eye pain or pulling with movement.
   Inflamed muscles hurt when stretched. People feel an ache when they try to look toward the tight muscle’s opposite direction.

5. Head tilt or turn to avoid double vision.
   The brain can fuse images in a certain head position. People adopt a chin-up, chin-down, face-turn, or head-tilt posture to help.

6. Reading difficulty.
   Close work needs precise alignment. Small misalignments cause words to shadow or jump. People lose their place and need frequent breaks.

7. Driving difficulty.
   Distance vision and side gaze are often affected. Lane changes and checking mirrors can trigger double vision and anxiety.

8. Eye strain and fatigue.
   The brain tries hard to fuse the two images. This effort causes tired eyes, brow ache, and poor concentration.

9. Blurred vision that comes and goes.
   Tear film instability from exposure and dry eye causes fluctuating blur. Blur worsens double vision symptoms.

10. Depth perception loss.
    When the eyes do not align, stereovision is reduced. Stairs, pouring liquids, and sports become harder.

11. Light sensitivity and glare.
    Surface irritation makes eyes more sensitive to light. Glare makes fusion harder and symptoms worse.

12. Eyelid retraction and stare.
    The eyelids sit high. More white of the eye shows above the cornea. This increases dryness and discomfort.

13. Bulging eyes (proptosis).
    The eyes sit forward. Lids may not close fully at night. Morning blur and irritation are common.

14. Headache and neck pain.
    Abnormal head postures and prolonged squinting lead to muscle tension headaches and neck aches.

15. Emotional stress and reduced quality of life.
    Double vision interferes with work, reading, and driving. People worry about appearance and safety.

---

Diagnostic tests

A) Physical exam tests

1. Visual acuity with and without pinhole.
   You read letters on a chart. Pinhole testing reduces the effect of surface blur. This shows whether blur is from the cornea or something else. In TED, acuity may be normal but can drop with dryness or, rarely, optic nerve compression.

2. Pupil exam for a relative afferent pupillary defect (RAPD).
   The doctor shines a light between eyes to see how pupils react. A weak response in one eye suggests optic nerve stress. This is important in severe TED with apical crowding.

3. Ocular alignment inspection and Hirschberg light reflex.
   A small light is shined at the eyes. The doctor checks where the reflection falls on each cornea. Offset reflections suggest misalignment. This is a quick, bedside way to screen for strabismus.

4. Ocular motility in nine positions of gaze.
   You follow a target up, down, left, right, and diagonals. The examiner notes where movement stops or is limited. TED typically shows a “hard stop” in the direction opposite the tight muscle.

B) Manual and orthoptic tests

5. Cover–uncover test.
   One eye is covered and then uncovered while you look at a target. A movement when the cover is moved shows a tropia. This identifies which eye is deviating in primary gaze.

6. Alternate cover test with prism neutralization.
   The cover is moved back and forth between eyes to break fusion. Prisms of known strength are placed until the eye no longer moves when uncovered. This measures the exact angle of strabismus at distance and near.

7. Prism and alternate cover test in multiple gazes (versions).
   The same prism method is used while you look left, right, up, and down. This shows how the angle changes with gaze and helps map restrictive patterns.

8. Head-tilt test (Bielschowsky).
   You tilt your head to each shoulder. Changes in vertical deviation with tilt help detect torsional or oblique involvement. In TED, this can reveal a torsional component or differentiate from nerve palsies.

9. Forced duction test (FDT).
   With numbing drops, the doctor gently grasps the eye with forceps and tries to move it. If the eye will not move, a mechanical restriction is present. A positive FDT supports TED restriction rather than a nerve palsy.

C) Laboratory and pathological tests

10. Thyroid-stimulating hormone (TSH).
    This blood test screens thyroid function. Low TSH suggests hyperthyroidism. High TSH suggests hypothyroidism. Abnormal levels often accompany TED, though TED severity does not always match hormone levels.

11. Free thyroxine (Free T4) and triiodothyronine (T3).
    These tests show how active thyroid hormone is in your blood. They guide medical control of the thyroid, which helps calm the eye disease over time.

12. TSH-receptor antibodies (TRAb) or thyroid-stimulating immunoglobulins (TSI).
    These antibodies drive Graves’ disease. A positive result supports the diagnosis and can correlate with TED activity.

13. Anti-TPO and anti-thyroglobulin antibodies.
    These antibodies suggest autoimmune thyroid disease. They are not specific for TED but help define the autoimmune background.

14. Orbital tissue biopsy (rare, rule-out test).
    If the picture is atypical, a small sample of orbital tissue can be examined. This rules out other causes like tumors, lymphoma, or infections. TED usually does not need a biopsy because imaging is characteristic.

D) Electrodiagnostic tests

15. Visual evoked potentials (VEP).
    You look at a flashing checkerboard while scalp electrodes record signals. Delayed or reduced signals suggest optic nerve stress from apical crowding. This helps when the pupil exam and vision changes are subtle.

16. Electro-oculography (EOG) or eye-movement recording.
    Sticky skin electrodes track eye movements while you follow lights. Restricted movement patterns and reduced velocities match tight muscles. This provides an objective record of the restriction.

E) Imaging tests

17. CT scan of the orbits.
    A CT shows bone and muscle shape very clearly. In TED, the eye muscles are enlarged, and the tendons are usually spared. The scan also shows how crowded the apex is and helps plan decompression surgery if needed.

18. MRI of the orbits with fat suppression.
    MRI shows the water content of tissues. In active disease, the muscles look bright on certain sequences, which means inflammation. In inactive disease, the muscles look thick but less bright, which means fibrosis. MRI guides timing of treatment.

19. Orbital ultrasound (B-scan).
    An ultrasound probe gently touches the closed eyelid with gel. It measures muscle thickness and can show tendon sparing. It is quick and does not use radiation.

20. Optical coherence tomography (OCT) of the optic nerve and macula.
    OCT is a light-based scan that measures retinal nerve fiber layers. Thinning suggests optic nerve damage from crowding. Macular OCT can also rule out other causes of vision symptoms.

Non-pharmacological treatments

1. Stop smoking (and avoid secondhand smoke).
   Purpose: Reduce the risk and severity of TED and flare-ups.
   Mechanism: Smoking amplifies immune activity and tissue hypoxia around the eye, worsening inflammation and scarring; quitting lowers that drive. (Reinforced across consensus guidance. PMC)

2. Keep thyroid levels steady (reach and maintain euthyroidism).
   Purpose: Prevent TED from starting or getting worse and stabilize eye alignment.
   Mechanism: Big swings in thyroid hormones can drive immune activity; good endocrine control reduces that trigger. (Consensus statements emphasize tight thyroid control. PMC)

3. If radioiodine (RAI) is used for Graves’ hyperthyroidism, use proper eye risk management.
   Purpose: Lower the chance of TED worsening after RAI.
   Mechanism: In at-risk patients (especially smokers or active TED), doctors often add prophylactic steroids or choose alternative thyroid treatments to protect the eyes. (Outlined in guidelines. PMC)

4. Prism glasses (Fresnel or ground-in).
   Purpose: Provide single vision without surgery for small, stable deviations or as a bridge while TED settles or after decompression.
   Mechanism: Prisms bend incoming light so the two images overlap on the retina, eliminating diplopia without moving the eyes. (Described in ophthalmology references. EyeWiki)

5. Temporary occlusion (patching, Bangerter foils).
   Purpose: Immediate relief from disturbing double vision when prisms cannot correct it.
   Mechanism: Blurring or blocking one eye stops the brain from seeing two separate images.

6. Elevate the head of the bed (two pillows) and reduce salt.
   Purpose: Lessen morning eyelid/cheek swelling and pressure sensations.
   Mechanism: Gravity and lower fluid retention reduce venous congestion and tissue edema around the orbit.

7. Cool compresses during active flares.
   Purpose: Calm redness and puffiness and soothe discomfort.
   Mechanism: Cold constricts surface blood vessels and reduces inflammatory mediator activity.

8. Protective eyewear and sunglasses outdoors.
   Purpose: Reduce wind, dust, and light sensitivity that increase irritation and reflex tearing.
   Mechanism: Physical barrier and UV filtering protect an already stressed ocular surface.

9. Humidifier and blink breaks (20-20-20 rule).
   Purpose: Ease dryness that often accompanies TED and makes diplopia more bothersome.
   Mechanism: Moist air plus regular complete blinks maintains the tear film and surface health.

10. Nighttime eyelid taping or moisture chamber goggles (if exposure).
    Purpose: Prevent the cornea from drying when lids do not close completely.
    Mechanism: Creates a sealed environment so the cornea stays wet overnight.

11. Driving and work-safety adjustments.
    Purpose: Avoid accidents during periods of unstable double vision.
    Mechanism: Limit night driving, use prism/occlusion, and adjust monitor height to match your single-vision field.

12. Orthoptic guidance and head-posture coaching.
    Purpose: Help you find a comfortable field of single vision for key tasks.
    Mechanism: Trained positioning and task-specific strategies reduce symptom burden even if underlying restriction persists.

13. Weight management and sleep optimization (treat sleep apnea if present).
    Purpose: Improve overall inflammatory balance and venous return from the orbit.
    Mechanism: Better sleep and treating OSA can reduce nocturnal hypoxia and tissue congestion, indirectly helping eye comfort and swelling.

14. Stress-reduction practices (mindfulness, CBT, relaxation).
    Purpose: Support coping and reduce symptom perception during flares.
    Mechanism: Lower sympathetic drive may help modulate immune signals and improve adherence to care.

15. Radiotherapy (orbital radiation) — non-drug medical therapy.
    Purpose: In selected patients with progressive diplopia and active TED, reduce motility inflammation and improve alignment.
    Mechanism: Low-dose radiation dampens inflammatory cells in the extraocular muscles; often combined with steroids. (Preferred in carefully chosen cases per consensus. PMCAAO Journal)

16. Regular measurement of deviation (orthoptics, Hess or Lancaster charts).
    Purpose: Know when measurements become stable and ready for surgery planning.
    Mechanism: Serial measurements detect change vs stability to time surgery correctly. (Stability 4–6 months is a common surgical threshold. PMC)

17. Sun/UV and wind control at work/home (wraparound eyewear).
    Purpose: Reduce surface irritation that magnifies visual discomfort.
    Mechanism: Barrier reduces evaporation and environmental triggers.

18. Ergonomic changes for reading/monitor use.
    Purpose: Place text within your binocular single-vision field to reduce diplopia strain.
    Mechanism: Height/angle adjustments put your eyes in a less restricted gaze.

19. Early referral to a multidisciplinary team (endocrinology + oculoplastics/strabismus).
    Purpose: Coordinate thyroid control, timing of decompression, and surgical planning.
    Mechanism: Sequencing care prevents step-back problems (e.g., decompression after strabismus can undo alignment). (Standard sequencing is emphasized in reviews and EyeWiki/AAO resources. EyeWiki)

20. Patient education and support groups.
    Purpose: Improve understanding, adherence, and mental health during a long, staged treatment journey.
    Mechanism: Knowledge reduces anxiety and helps patients apply practical home measures.

---

Drug treatments

⚠️ Safety note: Doses below are typical adult ranges used in published guidance or clinical trials; your exact regimen must be individualized by your specialist based on activity, severity, comorbidities, and local protocols.

1. Intravenous methylprednisolone (IVMP) — glucocorticoid
   Dose/Time: Common EUGOGO regimen totals 4.5 g over 12 weekly infusions (e.g., 500 mg weekly ×6, then 250 mg weekly ×6).
   Purpose: First-line in active moderate-to-severe TED to reduce inflammation, pain, redness, and motility restriction.
   Mechanism: Broad anti-inflammatory immune suppression in EOM and orbital tissues.
   Side effects: Blood sugar rise, blood pressure elevation, mood/sleep change, infection risk; rare but serious liver toxicity—hence careful cumulative-dose limits and monitoring. (EUGOGO 2021. PubMedBOPSS :)

2. Mycophenolate (mofetil or sodium) — antimetabolite immunosuppressant
   Dose/Time: Often MMF 1 g twice daily or mycophenolate sodium 720 mg twice daily; frequently combined with IVMP in modern protocols.
   Purpose: Enhances and prolongs steroid benefit; can help control active disease.
   Mechanism: Inhibits lymphocyte proliferation and autoimmunity driving TED.
   Side effects: GI upset, lowered white counts, infection risk, teratogenicity (pregnancy prevention needed). (EUGOGO endorses the IVMP + mycophenolate combination. PubMed)

3. Oral prednisone — glucocorticoid
   Dose/Time: Often 0.5–1 mg/kg/day, then taper; sometimes used when IVMP is not feasible.
   Purpose: Reduce active inflammation; less preferred vs IVMP due to side-effect profile.
   Mechanism: Same as above.
   Side effects: Weight gain, mood changes, insomnia, osteoporosis, diabetes/worsened glucose, infection.

4. Teprotumumab (Tepezza®) — IGF-1 receptor inhibitor (monoclonal antibody)
   Dose/Time: 8 infusions over 21 weeks (initial 10 mg/kg, then 20 mg/kg every 3 weeks ×7).
   Purpose: Approved for active TED to reduce proptosis, improve diplopia, and quality of life.
   Mechanism: Blocks IGF-1R signaling on orbital fibroblasts, which cross-talk with TSH receptors to drive edema and muscle/fat changes.
   Side effects: Muscle cramps, hyperglycemia (caution in diabetes), hearing symptoms, infusion reactions; avoid in pregnancy. (Phase 2 and 3 NEJM trials showed improvements in proptosis and diplopia vs placebo. New England Journal of Medicine+1)

5. Rituximab — anti-CD20 B-cell depleting biologic
   Dose/Time: Commonly 1000 mg IV, repeated once in 2 weeks; other regimens exist.
   Purpose: Option for glucocorticoid-resistant active disease in selected patients.
   Mechanism: Reduces autoantibody-producing B cells.
   Side effects: Infusion reactions, infections, rare PML; requires vaccination review and monitoring. (Evidence mixed but acceptable in select cases per consensus. PMC)

6. Tocilizumab — IL-6 receptor inhibitor
   Dose/Time: 8 mg/kg IV monthly or 162 mg SC (per local protocols) for steroid-resistant active disease.
   Purpose: Inactivate persistent inflammation and improve motility signs.
   Mechanism: Blocks IL-6 pathway, a key inflammatory driver.
   Side effects: Elevated liver enzymes, lipid changes, infection risk. (Consensus notes use in GC-resistant TED. PMC)

7. Botulinum toxin A (extraocular muscle injection) — neuromuscular blocker
   Dose/Time: Specialist-delivered 2.5–5 units into the antagonist or tight muscle; effect lasts weeks to months.
   Purpose: Temporary relief of diplopia and improved comfort during the active phase or while awaiting surgery.
   Mechanism: Reduces acetylcholine release, relaxing the injected muscle and balancing pull.
   Side effects: Temporary ptosis, worsened diplopia, dry eye; requires expert dosing.

8. Antithyroid drugs (e.g., methimazole/carbimazole) — thyroid hormone synthesis inhibitors
   Dose/Time: Methimazole 5–30 mg/day adjusted to labs.
   Purpose: Stabilize thyroid status, which indirectly protects the eyes and helps align care timing.
   Mechanism: Reduces thyroxine production, lowering autoimmune stimulation.
   Side effects: Rash, liver enzyme rise, rare agranulocytosis (seek urgent care if fever/sore throat).

9. Cyclosporine (selected cases) — calcineurin inhibitor
   Dose/Time: 2–5 mg/kg/day (specialist-managed).
   Purpose: Alternative/adjunct immunosuppression when first-line options are unsuitable.
   Mechanism: T-cell suppression.
   Side effects: Kidney dysfunction, hypertension, gum changes; drug interactions.

10. Azathioprine or Methotrexate (selected cases) — antimetabolite/antifolate
    Dose/Time: Azathioprine ~1–2 mg/kg/day; Methotrexate weekly with folate.
    Purpose: Second-line steroid-sparing strategies in centers experienced with them.
    Mechanism: Dampen lymphocyte proliferation.
    Side effects: Cytopenias, liver toxicity; require lab monitoring.

---

Dietary molecular supplements

⚠️ Important: Only selenium has strong randomized-trial evidence in TED (mild, active disease in selenium-deficient regions). The other items below are general anti-inflammatory/antioxidant supports with limited or indirect evidence for TED. Always discuss supplements with your doctor to avoid drug interactions and to personalize doses.

1. Selenium — 100 μg twice daily (selenium selenite/selenomethionine) for ~6 months.
   Function: In mild active TED, improved quality of life and slowed disease progression in a randomized trial.
   Mechanism: Antioxidant, supports selenoproteins that quench orbital oxidative stress. (NEJM RCT. New England Journal of MedicinePubMed)

2. Omega-3 fish oil (EPA/DHA) — 1–2 g/day combined EPA+DHA.
   Function: General anti-inflammatory support; may ease ocular surface symptoms.
   Mechanism: Competes with arachidonic acid to lower pro-inflammatory eicosanoids.

3. Vitamin D3 — 1000–2000 IU/day (adjust to blood levels).
   Function: Immune modulation if deficient.
   Mechanism: Regulates T-cell responses and cytokines.

4. Vitamin C — 500–1000 mg/day.
   Function: Antioxidant support; collagen crosslinking cofactor.
   Mechanism: Reduces reactive oxygen species that fuel inflammation.

5. Vitamin E — 200–400 IU/day.
   Function: Lipid-phase antioxidant; may complement vitamin C.
   Mechanism: Scavenges free radicals in cell membranes.

6. Zinc — 10–20 mg/day (monitor copper if long term).
   Function: Supports antioxidant enzymes and immune balance.
   Mechanism: Cofactor for superoxide dismutase; influences cytokine signaling.

7. N-acetylcysteine (NAC) — 600 mg 1–2×/day.
   Function: Replenishes glutathione; potential anti-fibrotic effects.
   Mechanism: Thiol donor that neutralizes oxidants and may modulate TGF-β pathways.

8. Coenzyme Q10 — 100–200 mg/day.
   Function: Mitochondrial support and antioxidant; may help energy and fatigue.
   Mechanism: Electron transport chain cofactor; scavenges free radicals.

9. L-carnitine — 1–2 g/day (in divided doses).
   Function: Fatty-acid transport into mitochondria; potential muscle metabolism support.
   Mechanism: Shifts energy metabolism; theoretical benefit in muscle stress states.

10. Curcumin (with piperine for absorption) — 500–1000 mg/day standardized curcuminoids.
    Function: Broad anti-inflammatory activity.
    Mechanism: Down-regulates NF-κB and pro-inflammatory cytokines.

---

Regenerative / stem-cell”-type drugs

⚠️ Plain truth: There are no approved “stem-cell drugs” for TED or TED-strabismus. “Hard immunity boosters” is not the right goal—TED improves by calming an overactive immune response, not boosting it. Below are advanced immunomodulators and experimental approaches, with cautious notes:

1. Teprotumumab (approved)
   Function/Mechanism: IGF-1R blockade reduces the orbital fibroblast–immune loop; improves proptosis and often diplopia in active TED.
   Dose: 8 infusions over 21 weeks; see details above.
   Note: Not regenerative; it is disease-modifying. Monitor glucose and hearing. (NEJM trials. New England Journal of Medicine)

2. Rituximab (select, off-label for TED)
   Function/Mechanism: B-cell depletion reduces autoantibody drivers.
   Dose: 1000 mg IV ×2, 2 weeks apart (common regimen).
   Note: Mixed evidence; used in glucocorticoid-resistant active cases. (Consensus. PMC)

3. Tocilizumab (select, off-label for TED)
   Function/Mechanism: IL-6 pathway inhibition in steroid-resistant active disease.
   Dose: IV or SC regimens per rheumatology protocols.
   Note: Monitor for infections and liver test changes. (Consensus. PMC)

4. Mycophenolate (adjunct)
   Function/Mechanism: Steroid-sparing immunosuppression; part of EUGOGO first-line combo with IVMP.
   Dose: See above.
   Note: Contraception mandatory; teratogenic. (EUGOGO. PubMed)

5. Orbital radiotherapy (non-drug advanced therapy)
   Function/Mechanism: Targets lymphocytes and fibroblasts in extraocular muscles; can help progressive diplopia in active TED.
   Dose: Given as low-dose fractions by radiation oncology.
   Note: Used selectively; often with steroids. (Consensus and AAO review. PMCAAO Journal)

6. Investigational biologics (future options)
   Function/Mechanism: Additional IGF-1R antagonists and other pathway blockers are under study to match or improve upon teprotumumab effects, including on diplopia; these are not approved as of today.
   Note: Participation only via clinical trials with informed consent; dosing is protocol-specific. (Ongoing pipeline highlighted in recent consensus/updates; avoid off-label hype. American Thyroid Association)

---

Surgeries

Sequence matters: If needed, orbital decompression is performed first, strabismus surgery second, and eyelid surgery last. Strabismus surgery is usually delayed until measurements are stable for ~4–6 months after the active phase. (This sequencing is standard to avoid undoing previous work. PMCEyeWiki)

1. Orbital decompression (if proptosis or optic nerve risk).
   Procedure: Bone and/or fat are removed from the orbit to create more space.
   Why: Reduces eye bulging and pressure; may change muscle paths, which is why decompression is performed before strabismus surgery. (AAO/EyeWiki stress the order of operations. EyeWiki)

2. Inferior rectus recession with adjustable suture (for hypotropia/upgaze block).
   Procedure: The tight inferior rectus is moved back (recessed) from the eye to reduce its downward pull; an adjustable knot allows fine-tuning after surgery.
   Why: This is the workhorse operation for vertical TED-strabismus. Resections are generally avoided because tight, fibrotic muscles do not behave like normal ones and resection risks overcorrection. (PPP and EyeWiki endorse recessions and adjustable sutures. American Academy of OphthalmologyEyeWiki)

3. Medial rectus recession ± lateral rectus procedure (for esotropia).
   Procedure: The tight medial rectus is recessed; in large angles, a lateral rectus resection or plication may be added in selected cases.
   Why: Restores distance alignment and side gaze. Surgeons use forced-duction testing and imaging to plan amounts. (Review guidance. PMC)

4. Oblique muscle procedures (torsion management).
   Procedure: Inferior oblique weakening or superior oblique tuck/Harada-Ito to correct image tilt.
   Why: Reduces torsional diplopia that prisms cannot fix.

5. Adjustable-suture fine-tuning strategy.
   Procedure: Using adjustable knots, alignment is refined in the hours–days after surgery when the patient is awake and can report diplopia.
   Why: TED muscles are unpredictable; adjustable sutures increase the chance of landing on single vision. (Systematic reviews suggest benefit in complex adult strabismus, though high-quality evidence is limited; still widely used in TED. CochraneEyeWiki)

---

Prevention

1. Stop smoking and avoid secondhand smoke.

2. Keep thyroid hormones stable with regular labs and medication adherence.

3. Discuss TED risk before RAI; use steroid prophylaxis if appropriate or consider alternatives. PMC

4. Treat sleep apnea and optimize sleep.

5. Manage diabetes, blood pressure, and lipids to support healing and reduce steroid risks.

6. Use protective eyewear outdoors and in dusty/windy settings.

7. Lower dietary salt to reduce edema.

8. Plan screen and reading ergonomics to stay within your single-vision field.

9. Seek early specialist referral if you notice new diplopia or eye bulging.

10. Keep regular follow-ups so changes are caught early and surgery is timed correctly.

---

When to see a doctor

• New or worsening double vision, especially with headaches, eye pain, or nausea.

• Sudden drop in vision, dimmer colors, or shadow over vision.

• Eye pain with eye movement, severe redness, or swelling that is getting worse.

• Rapidly increasing bulging or inability to close the eye fully (risk of corneal injury).

• Severe dryness or non-healing corneal spots, light sensitivity, or discharge.

• Any change during pregnancy, after radioiodine, or while starting/stopping steroids or biologics.

• Persistent diplopia that interferes with driving, reading, or work despite prisms/patching.

---

What to eat — and what to avoid

To eat (focus on balance and anti-inflammatory patterns)

1. Selenium-rich foods: Brazil nuts (small amounts), tuna, sardines, eggs.

2. Fatty fish (omega-3s): salmon, mackerel.

3. Leafy greens: spinach, kale, rich in antioxidants.

4. Colorful vegetables and fruits: berries, peppers, tomatoes (vitamin C).

5. Whole grains: oats, brown rice for steady energy.

6. Legumes: lentils, beans for fiber and micronutrients.

7. Nuts/seeds: walnuts, flaxseed (omega-3 precursors).

8. Lean proteins: poultry, tofu, yogurt (helps muscle recovery).

9. Olive oil as main fat.

10. Plenty of water to support tear film and reduce salt concentration.

To avoid/limit

1. High-iodine supplements/kelp (unless prescribed) to avoid thyroid swings.

2. Very salty foods (packaged snacks, cured meats) that worsen edema.

3. Excess sugar and ultra-processed foods that promote inflammation.

4. Excess alcohol, which dehydrates and disrupts sleep.

5. Energy drinks and large caffeine spikes if they worsen dryness/anxiety.

6. Smoking (including vaping) and exposure to secondhand smoke.

7. Unverified “thyroid boosters” marketed online; they can destabilize hormone levels.

8. Mega-dosing vitamins without labs—stick to evidence-guided dosing.

9. Late-night heavy meals that impair sleep quality.

10. Any supplement that interacts with your meds (check with your doctor).

---

Frequently asked questions

1) Why does TED cause double vision?
Inflammation makes certain eye muscles swollen and later fibrotic and tight. Tight muscles hold the eye in one position and block opposite movement, so the eyes point in different directions in some gazes and you see double.

2) Which muscles are usually responsible?
Most commonly the inferior rectus (causing down-pull and upgaze problems) and the medial rectus (causing inward turning and distance diplopia). Others can be involved too.

3) Will prisms fix my double vision forever?
Prisms can fully correct small, stable misalignments or temporarily help while your TED settles or after decompression while you wait for surgery. Large, changing deviations usually need surgery. EyeWiki

4) Do eye exercises help?
In restrictive TED-strabismus, exercises alone rarely fix the problem because the muscle is mechanically tight. Exercises may help comfort and coordination but don’t release a scarred muscle.

5) When is the right time for strabismus surgery?
After any needed orbital decompression and when measurements are stable for ~4–6 months in the inactive phase. That timing improves accuracy and durability. PMC

6) Why do surgeons prefer muscle recessions (and adjustable sutures) in TED?
Recession weakens a tight, fibrotic muscle safely. Adjustable sutures let surgeons fine-tune alignment after surgery because TED muscles are unpredictable. Resections are generally avoided. (PPP/EyeWiki. American Academy of OphthalmologyEyeWiki)

7) Can medicines alone cure TED-strabismus?
Medicines (steroids, biologics like teprotumumab) can reduce active inflammation and may improve diplopia, but long-standing fibrosis often leaves a fixed deviation that still needs surgery. (Teprotumumab trials documented diplopia improvement during active disease. New England Journal of Medicine)

8) Is orbital radiation safe and useful?
In selected patients with progressive diplopia in active disease, low-dose orbital radiotherapy can help eye movements—often combined with steroids. It’s not for everyone and is carefully planned by specialists. PMC

9) Does selenium really help?
Yes—in mild, active TED in areas with low selenium, 100 μg twice daily improved quality of life and slowed progression in a randomized trial. It is not a cure for large deviations. New England Journal of Medicine

10) Will surgery affect my proptosis (bulging)?
Strabismus surgery does not reduce proptosis. If bulging needs treatment, decompression surgery is done before eye-muscle surgery. EyeWiki

11) Can strabismus surgery be one-and-done?
Often yes, but some patients need more than one operation because TED muscles and healing are variable. Your team will discuss probabilities based on your measurements.

12) Why might double vision change after decompression?
Decompression can alter muscle paths and balance, sometimes unmasking or changing misalignment. That is why surgeons wait to measure stability after decompression before operating on muscles. EyeWiki

13) Are there “stem-cell” cures for TED-strabismus?
No approved stem-cell treatments exist for TED eye muscles. Research is ongoing, but current care relies on immunomodulation, radiotherapy in select cases, and surgery.

14) Can I drive with double vision?
You must meet local legal standards and, most importantly, see single while driving. Temporary occlusion or prisms may be required. If you cannot achieve safe single vision, do not drive.

15) What is the usual treatment journey?
(1) Control thyroid and lifestyle risks → (2) manage ocular surface and diplopia with prisms/occlusion → (3) treat active inflammation (steroids ± mycophenolate; teprotumumab or other biologics in selected cases; ± orbital radiotherapy) → (4) if needed, orbital decompression → (5) strabismus surgery once stable → (6) eyelid surgery if needed. (This stepwise plan is consistent across consensus guidance. PMC)

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: August 26, 2025.

PDF Document For This Disease Conditions References